Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEBULA: Nebulized Lignocaine for Bronchoscopy
NCT03040193Completed
- Sponsor
- AIIMS New Delhi
- Start
- Mar 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by AIIMS New Delhi. Primary endpoints: Operator rated overall procedure satisfaction VAS at 12 months and Operator rated cough VAS at 12 months. Started Mar 2017; status: completed.
02
Drugs
lidocaine
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT03040193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03040193.